Wang J - Search Results

1

Wang ZB, Zhang X, Xiao F, Liu ZQ, Liao QJ, Wu N, Wang J. Wang ZB, et al. Among authors: wang j. Biochem Pharmacol. 2023 Nov;217:115857. doi: 10.1016/j.bcp.2023.115857. Epub 2023 Oct 13. Biochem Pharmacol. 2023. PMID: 37839677 Free article. Review.

2

Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer.

Li H, Liu ZY, Chen YC, Zhang XY, Wu N, Wang J. Li H, et al. Among authors: wang j. Front Oncol. 2022 Oct 12;12:999654. doi: 10.3389/fonc.2022.999654. eCollection 2022. Front Oncol. 2022. PMID: 36313727 Free PMC article.

3

USP7 mediates TRAF4 deubiquitination to facilitate the malignant phenotype of ovarian cancer via the RSK4/PI3K/AKT axis.

Wang Y, Luo X, Wu N, Liao Q, Wang J. Wang Y, et al. Among authors: wang j. J Cancer Res Ther. 2023 Feb;19(1):97-107. doi: 10.4103/jcrt.jcrt_517_22. J Cancer Res Ther. 2023. PMID: 37006049 Free article.

4

Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy.

Wang ZB, Zhang X, Fang C, Liu XT, Liao QJ, Wu N, Wang J. Wang ZB, et al. Among authors: wang j. Immunology. 2024 Sep;173(1):14-32. doi: 10.1111/imm.13793. Epub 2024 Apr 15. Immunology. 2024. PMID: 38618976 Review.

5

Progesterone Enhances Niraparib Efficacy in Ovarian Cancer by Promoting Palmitoleic-Acid-Mediated Ferroptosis.

Wu N, Zhang X, Fang C, Zhu M, Wang Z, Jian L, Tan W, Wang Y, Li H, Xu X, Zhou Y, Chu TY, Wang J, Liao Q. Wu N, et al. Among authors: wang z, wang j, wang y. Research (Wash D C). 2024 May 24;7:0371. doi: 10.34133/research.0371. eCollection 2024. Research (Wash D C). 2024. PMID: 38798714 Free PMC article.

6

Predicting progression-free survival in patients with epithelial ovarian cancer using an interpretable random forest model.

Jian L, Chen X, Hu P, Li H, Fang C, Wang J, Wu N, Yu X. Jian L, et al. Among authors: wang j. Heliyon. 2024 Jul 26;10(15):e35344. doi: 10.1016/j.heliyon.2024.e35344. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39166005 Free PMC article.

7

Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer.

Xiao F, Wang Z, Qiao L, Zhang X, Wu N, Wang J, Yu X. Xiao F, et al. Among authors: wang z, wang j. J Transl Med. 2024 Aug 21;22(1):778. doi: 10.1186/s12967-024-05583-z. J Transl Med. 2024. PMID: 39169400 Free PMC article. Review.

8

Correction: TRPM7 promotes the epithelial- mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.

Liu L, Wu N, Wang Y, Zhang X, Xia B, Tang J, Cai J, Zhao Z, Liao Q, Wang J. Liu L, et al. Among authors: wang j, wang y. J Exp Clin Cancer Res. 2024 Oct 21;43(1):291. doi: 10.1186/s13046-024-03212-7. J Exp Clin Cancer Res. 2024. PMID: 39434150 Free PMC article. No abstract available.

9

Targets and beyond: cancer stem cell elimination.

Wu A, Shu G, Wang J, Yin G. Wu A, et al. Among authors: wang j. Sci Bull (Beijing). 2017 Aug 30;62(16):1104-1105. doi: 10.1016/j.scib.2017.07.013. Epub 2017 Aug 10. Sci Bull (Beijing). 2017. PMID: 36659339 No abstract available.

10

[Explanation and interpretation of blood transfusion provisions for children with hematological diseases in the national health standard "Guideline for pediatric transfusion"].

Zhao MY, Huang R, Gui R, He QN, Hei MY, Zhu XF, Lu J, Xu XJ, Yuan TM, Zhang R, Wang X, Liu JP, Wang J, Shao ZL, Guo YJ, Wu XY, Chen JR, Chen QR, Guo J, Yang MH. Zhao MY, et al. Among authors: wang x, wang j. Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jan 15;27(1):18-25. doi: 10.7499/j.issn.1008-8830.2410093. Zhongguo Dang Dai Er Ke Za Zhi. 2025. PMID: 39825647 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219,956 results

Search Page

Filters